COVID‐19 and liver disease
Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti – 6 April 2020
COVID‐19 and liver disease
Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti – 6 April 2020
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
Mark W. Douglas, Enoch S.E. Tay, Dao Sen Wang, Adrian T.L. Ong, Caroline Wilson, Amy Phu, Jen Kok, Dominic E. Dwyer, Rowena A. Bull, Andrew R. Lloyd, Tanya L. Applegate, Gregory J. Dore, Anita Y. Howe, Richard Harrigan, Jacob George – 6 April 2020 – Direct acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment, but drug resistance could undermine proposed global elimination targets. Real‐world studies are needed to inform the impact of widespread DAA treatment on antiviral resistance in the community.
Novel Therapies for Managing Cholestasis
Priscila Santiago, Cynthia Levy – 4 April 2020
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni – 4 April 2020 – At present, there is scarce information regarding the global prevalence of chronic liver disease in individuals with coronavirus disease 2019 (COVID‐19) disease, which is becoming a global pandemic. The aim of this study was to assess the overall prevalence of chronic liver disease among patients with COVID‐19 disease by meta‐analysing data in observational studies and to investigate the relationship between liver damage and COVID‐19 disease.
Let’s not forget our COVID‐19‐free cirrhotic patients!
Mauro Viganò, Marco Carbone – 4 April 2020
Letter to the Editor: A Prognostic Algorithm Based on Stage of Cirrhosis and Hepatic Venous Pressure Gradient to Improve Risk Stratification After Variceal Bleeding
Ashish Kumar, Praveen Sharma, Anil Arora – 4 April 2020
Bile Acid Biology, Pathophysiology, and Therapeutics
John Y.L. Chiang, Jessica M. Ferrell – 4 April 2020
Let’s not forget our COVID‐19‐free cirrhotic patients!
Mauro Viganò, Marco Carbone – 4 April 2020
Bile Composition as a Diagnostic and Prognostic Tool in Liver Transplantation
Isabel M. A. Brüggenwirth, Robert J. Porte, Paulo N. Martins – 4 April 2020 – Bile secretion and composition reflects the functional status of hepatocytes and cholangiocytes. Bile composition can have a role in the assessment of donor grafts before implantation in the recipient. In addition, changes in bile composition after liver transplantation can serve as a diagnostic and prognostic tool to predict posttransplant complications, such as primary nonfunction, acute cellular rejection, or nonanastomotic biliary strictures.